4//SEC Filing
Gallagher Carol Giltner 4
Accession 0000905148-23-001457
CIK 0001604464other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 5:07 PM ET
Size
6.3 KB
Accession
0000905148-23-001457
Insider Transaction Report
Form 4
Gallagher Carol Giltner
Director
Transactions
- Purchase
Common Stock
2023-11-13$0.22/sh+179,020$40,029→ 368,438 total - Purchase
Common Stock
2023-11-14$0.31/sh+90,980$28,186→ 459,418 total
Footnotes (2)
- [F1]Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.205 to $0.251. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Form 4.
- [F2]Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2862 to $0.3229.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001329959
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 5:07 PM ET
- Size
- 6.3 KB